內臟痛治療市場:各藥物類型，各適應症，各流通管道，各地區-2023年～2030年的市場規模，佔有率，展望，機會分析

Visceral Pain Treatment Market, By Drug Type (Pain Modifiers, Analgesics, and Others) By Indications and By Distribution Channels By Region - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

出版日期: 2023年07月18日 | 出版商:

Coherent Market Insights | 英文 130 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

內臟疼痛是由骨盆、胸部和腹部等內臟器官（器官）中的傷害感受器活化引起的。內臟結構對拉伸、發炎和缺血高度敏感，但對經常引起疼痛的其他刺激（例如灼熱感或切割感）中等敏感。內臟疼痛的症狀包括嘔吐、噁心、生命徵象變化和情緒症狀。普瑞巴林和加巴噴丁是用來治療內臟疼痛的藥物。內臟痛是指子宮、胃、直腸、膀胱等內臟器官發炎所引起的內臟疼痛。這種發炎是由多種因素引起的，包括感染、創傷以及內臟器官的外部或內部損傷。內臟疼痛的強度各不相同，從劇烈持續性疼痛到有時深度疼痛。

市場動態

內臟疼痛治療方法的不斷增加預計將推動全球內臟疼痛治療市場的成長。例如，2022年12月31日，《美國生理學期刊》發表論文指出，慢性疼痛的有效治療方法很少。鴉片類藥物危機凸顯了迫切需要了解慢性疼痛的機制並開發新的治療方法，避免鴉片類藥物產生不可接受的副作用。急性疼痛是生存所必需的生理過程，使我們能夠識別並避免受傷。慢性疼痛可能與疾病（例如癌症、發炎性疾病、功能性胃腸道疾病、糖尿病）、損傷（例如神經外傷）或治療（例如化療）有關，並且可能在患者痊癒後發生，也可能持續存在。在內臟器官中，疼痛感受器不像其他器官那樣緊密排列和均勻分佈，因此很難識別和治療疼痛的原因。

本調查的主要特徵

本報告提供以2022年為基準年的預測期間（2023-2030 年）之全球內臟痛治療市場的市場規模和復合年增長率（CAGR %）相關的詳區隔析。
並闡明不同部門市場的潛在收入機會，說明該市場具有魅力的投資主張矩陣。
同時並提供市場推動因素和限制、機會、新產品發布或批准、市場趨勢、區域前景和主要參與者採用的競爭戰略等重要考察。
並基於企業亮點，各類型投資組合、主要焦點、財務業績和市場策略等參數，介紹全球內臟痛治療市場的主要參與者之企業簡介。
藉由該報告提供的洞察，將能幫助營銷人員和公司高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
全球內臟痛治療市場報告配合該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
利益相關者可以透過全球內臟痛治療市場用於分析的各種戰略矩陣來幫助他們更容易做下決策。

Visceral pain results from the activation of nociceptors in the viscera (organs) of the pelvis, chest, or abdomen. Visceral structures are very sensitive to stretching (stretching), inflammation, and ischemia, but moderately sensitive to other stimuli that often cause pain such as burning or cutting. Symptoms of visceral pain include vomiting, nausea, changes in vital signs, and emotional manifestations. Pregabalin or gabapentin are some drugs used to treat visceral pain. Visceral pain is defined as internal pain caused by inflammation of internal organs such as the uterus, stomach, rectum, and bladder. This inflammation is caused by several factors such as infection, trauma, and external or internal injuries to internal organs. Visceral pain varies in intensity from sharp, constant, or occasionally deep, like urgent at the body.

Market Dynamics

Increasing number of treatments of visceral pain are expected to drive the global visceral pain treatment market growth. For instance, on December 31, 2022, American Journal of Physiology published an article stating there are few effective treatments for chronic pain. The opioid crisis emphasizes the urgent need to clarify the mechanisms of chronic pain and to develop new forms of treatment that do not have the unacceptable side effects of opioids. Acute pain is a physiological process that is necessary for survival because it allows the awareness and avoidance of injury. Chronic pain can accompany disease (e.g., cancer, inflammatory diseases, functional GI disorders, and diabetes), injury (e.g., neurotrauma) and therapy (e.g., chemotherapy), and can persist after patient the patient is healed. In the visceral organs, pain receptors are not as closely packed and not as evenly spread out as in other organs, which makes the pain's origin much harder to pinpoint and treat.

Key features of the study:

This report provides an in-depth analysis of the global visceral pain treatment market and provides market size (US$ Bn) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global visceral pain treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
The key companies covered as a part of this study include Addex Therapeutics Ltd., AstraZeneca, Astellas Pharma Inc., Allergan, Chromocell Corporation, Takeda, GIcare Pharma Inc., Abbvie, Grunenthal GmbH, Johnson & Johnson, Neurim Pharmaceuticals Ltd, and Medestea Research & Production S.p.A.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global visceral pain treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global visceral pain treatment market

Detailed Segmentation:

Global Visceral Pain Treatment Market, By Drug Type:
- Pain modifiers
  - Tricyclic Anticonvulsant
  - Tricyclic Antidepressants
- Analgesics
  - Narcotics
  - NSAID
- Others
Global Visceral Pain Treatment Market, By Indication:
- Chronic Prostatitis
- Interstitial Cystitis
- Crohn's Disease
- Irritable Bowel Syndrome
Global Visceral Pain Treatment Market, By Distribution Channel:
- Hospital Pharmacy
- Retail Pharmacy
- Online Channels
Global Visceral Pain Treatment Market, By Region:
- North America
  - U.S.
  - Canada
- Latin America
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
- Europe
  - U.K.
  - Germany
  - France
  - Spain
  - Italy
  - Russia
  - Rest of Europe
- Asia Pacific
  - China
  - Japan
  - India
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - GCC Countries
  - Israel
  - Rest of Middle East
- Africa
  - North Africa
  - Central Africa
  - South Africa
Company Profiles
- Addex Therapeutics Ltd.
- AstraZeneca
- Astellas Pharma Inc.
- Allergan
- Chromocell Corporation
- Takeda
- GIcare Pharma Inc.
- Abbvie
- Grunenthal GmbH
- Johnson & Johnson
- Neurim Pharmaceuticals Ltd
- Medestea Research & Production S.p.A

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Drug Type
- Market Snapshot, By Indication
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Visceral Pain Treatment Market - COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Visceral Pain Treatment Market, By Drug Type, 2018-2030, (US$ Billion)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Pain modifiers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Tricyclic Anticonvulsant
Tricyclic Antidepressants
Analgesics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Narcotics
NSAID
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

6. Global Visceral Pain Treatment Market, By Indication , 2018-2030, (US$ Billion)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Chronic Prostatitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Interstitial Cystitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Crohn's Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Irritable Bowel Syndrome
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

7. Global Visceral Pain Treatment Market, By Distribution Channel , 2018-2030, (US$ Billion)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Hospital Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Retail Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)
Online Channels
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Billion)

8. Global Visceral Pain Treatment Market, By Region, 2018-2030, (US$ Billion)

Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2018-2030
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Indication , 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Indication , 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Indication , 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Indication , 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Indication , 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Billion)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Indication , 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel , 2018 - 2030, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2018-2030, (US$ Billion)
North Africa
Central Africa
South Africa

9. Competitive Landscape

Addex Therapeutics Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Astellas Pharma Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Allergan
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Chromocell Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Takeda
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
GIcare Pharma Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Abbvie
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Grunenthal GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Neurim Pharmaceuticals Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Medestea Research & Production S.p.A
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies